Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,746,920 papers from all fields of science
Search
Sign In
Create Free Account
Buserelin Acetate
Known as:
Acetate, Buserelin
, BSRL Acetate
, D-Ser (Bu(t))(6) Pro(9) NEt LHRH Acetate
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
Buserelin
Narrower (2)
HOE-766
Suprefact
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Induction of ovulation with buserelin in jennies: in search of the minimum effective dose.
F. Camillo
,
I. Vannozzi
,
+5 authors
D. Panzani
Animal Reproduction Science
2014
Corpus ID: 22665071
2008
2008
Delayed treatment with GnRH agonist, hCG and progesterone and reduced embryonic mortality in buffaloes.
G. Campanile
,
D. Vecchio
,
+5 authors
M. D’Occhio
Theriogenology
2008
Corpus ID: 205360595
1997
1997
Spectroscopic Characterization of the Inclusion Complex of a Luteinizing Hormone-Releasing Hormone Agonist, Buserelin Acetate, with Dimethyl-β-cyclodextriin
K. Matsubara
,
T. Irie
,
K. Uekama
1997
Corpus ID: 26333328
Inclusion complexation of buserelin acetate, an agonist of luteinizing hormone-releasing hormone, with dimethyl-β-cyclodextrin…
Expand
1997
1997
Protection Afforded by Maltosyl-β-cyclodextrin Against α-Chymotrypsin-Catalyzed Hydrolysis of a Luteinizing Hormone-Releasing Hormone Agonist, Buserelin Acetate
K. Matsubara
,
Y. Ando
,
T. Irie
,
K. Uekama
Pharmaceutical Research
1997
Corpus ID: 21798449
AbstractPurpose. The present study addresses how maltosyl-β-cyclodextrin (G2-β-CyD) impacts upon the α-chymotrypsin-catalyzed…
Expand
1995
1995
In Vivo CD3+CD25+ Lymphocyte Subpopulation Is Down‐regulated Without Increased Serum‐Soluble Interleukin‐2 Receptor (sIL‐2R) by Gonadotropin Releasing Hormone Agonist (GnRH‐a)
H. Ho
,
Ming-Yih Wu
,
+5 authors
T. Gill
American Journal of Reproductive Immunology
1995
Corpus ID: 25650058
PROBLEM: To test further whether the suppression of the CD3+CD25+ lymphocyte sub‐population by gonadotropin‐releasing hormone…
Expand
1994
1994
Use of follicle-stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitization.
M. Hull
,
R. J. Armatage
,
A. Mcdermott
Fertility and Sterility
1994
Corpus ID: 25298337
1994
1994
Effect of gonadotropin-releasing hormone agonist on the bone mineral density of patients with endometriosis.
T. Uemura
,
J. Mohri
,
H. Osada
,
N. Suzuki
,
N. Katagiri
,
H. Minaguchi
Fertility and Sterility
1994
Corpus ID: 29538448
Highly Cited
1993
Highly Cited
1993
The long protocol of administration of gonadotropin‐releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization
S. Tan
,
C. Kingsland
,
+5 authors
H. Jacobs
Fertility and Sterility
1993
Corpus ID: 24753022
Highly Cited
1991
Highly Cited
1991
Correlation of endometrial histology, morphometry, and ultrasound appearance after different stimulation protocols for in vitro fertilization.
P. Rogers
,
D. Polson
,
C. Murphy
,
M. Hosie
,
B. Susil
,
M. Leoni
Fertility and Sterility
1991
Corpus ID: 23023006
1989
1989
Sustained release of buserelin acetate, a luteinizing hormone‐releasing hormone agonist, from an injectable oily preparation utilizing ethylated β‐cyclodextrin
K. Uekama
,
H. Arima
,
T. Irie
,
K. Matsubara
,
T. Kuriki
The Journal of pharmacy and pharmacology
1989
Corpus ID: 32511946
Abstract— The possible use of heptakis (2,6‐di‐O‐ethyl)‐β‐cyclodextrin (DE‐β‐CyD) as a parenteral sustained‐release carrier for…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE